Dr. Omar Alhalabi, MD

Claim this profile

MD Anderson Cancer Center

Studies Transitional Cell Carcinoma
Studies Pancreatic Cancer
1 reported clinical trial
3 drugs studied

Area of expertise

1

Transitional Cell Carcinoma

Omar Alhalabi, MD has run 1 trial for Transitional Cell Carcinoma. Some of their research focus areas include:

MTAP positive
Stage IV
2

Pancreatic Cancer

Omar Alhalabi, MD has run 1 trial for Pancreatic Cancer. Some of their research focus areas include:

MTAP positive
Stage IV

Affiliated Hospitals

Image of trial facility.

M D Anderson Cancer Center

Clinical Trials Omar Alhalabi, MD is currently running

More about Omar Alhalabi, MD

Clinical Trial Related

2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial

Treatments Omar Alhalabi, MD has experience with

  • Etrumadenant
  • Pemetrexed
  • Zimberelimab

Breakdown of trials Omar Alhalabi, MD has run

Transitional Cell Carcinoma

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Omar Alhalabi, MD specialize in?

Is Omar Alhalabi, MD currently recruiting for clinical trials?

Are there any treatments that Omar Alhalabi, MD has studied deeply?

What is the best way to schedule an appointment with Omar Alhalabi, MD?

What is the office address of Omar Alhalabi, MD?

Is there any support for travel costs?